Delivery Order SPE2DB20D6037-SPE2DB22FD0KZ
Award Date 9/28/22
Potential Completion Date 9/29/22
Potential Value $2.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $3,292.43 award is for the delivery of a pharmaceutical product, hydroxyzine hydrochloride, with an ultimate completion date of June 26, 2024. The contract has no set-aside designation. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,700.62, is for the delivery of Hydroxyzine Hydrochloride, a prescription drug. DMS Pharmaceutical Group holds a larger indefinite-delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,466.07 delivery order is for 473 mL of hydroxyzine 10 mg/5 mL syrup. The order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,506.54, is for the delivery of hydroxyzine 50 mg/ml vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,138.07 firm fixed-price contract is for the delivery of hydroxyzine hydrochloride injection, a prescription medication. The contract is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with DLA, under the SPE2DB...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,228.98 firm fixed-price contract is for the delivery of 473 ml bottles of 10 mg/5 ml hydroxyzine syrup. The contract is not associated with a set-aside program and is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program....
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, which has a ceiling value of $4,150.40, is for the delivery of hydroxyzine hydrochloride injection, a pharmaceutical product. The contract has a firm fixed price pricing type and no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Vehicle (IDV) contract, SPE2DB, with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,898.82, is for the delivery of HYDROXYZINE HYDROCHLO, a pharmaceutical product, to support the medical supply needs of military health facilities. The contract has an ultimate completion date of November 22, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,428.02 firm fixed-price contract is for the delivery of HYDROXYZINE HYDROCHLO, with a period of performance through May 13, 2024. The award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of a pharmaceutical item - HYDROXYZINE 10MG/5 1S. The delivery order, valued at $1,430.64, is a firm fixed-price contract with a completion date of July 26, 2024. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that provides a wide range of pharmaceutical products and medical supplies to the U.S. federal government, primarily serving...